At the prestigious IMCAS World Congress 2025, a groundbreaking comparative study evaluating the top seven platelet-rich plasma (PRP) systems was presented by Prof. Pietro Gentile, Plastic Surgeon, Italy, and Prof. Jeremy Magalon, Pharmacologist, France. The presentation, titled 'PRODUCT ANALYSIS > comparative non-commercial study on a selection of products or devices currently available on the market', highlighted the performance of various PRP systems.
The results solidified T-Lab™ as the industry leader, achieving the highest rankings across key performance metrics, including platelet dose, platelet recovery rate, and overall system effectiveness.
Unmatched Performance in Platelet Concentration and Recovery
The study meticulously analysed 7 of the world's top PRP systems based on several critical factors essential to regenerative medicine and aesthetic applications. T-Lab™ emerged as the clear frontrunner with:
#1 Platelet Dose: 4.6 billion platelets, the highest concentration among all systems tested.
#1 Platelet Recovery Rate: 90.1%, demonstrating superior efficiency in extracting and preserving platelets.
#1 Overall System Ranking: Above 90% in all evaluated categories, showcasing its excellence across the board.
The Significance of These Findings
PRP therapy has become a cornerstone in regenerative medicine, aesthetics, and orthopaedics, making the efficacy of PRP systems a crucial factor for practitioners and patients alike. The findings presented at IMCAS World Congress 2025 reinforce T-Lab™’s reputation for providing the most effective and reliable PRP system available today.
A higher platelet dose translates to enhanced regenerative potential, contributing to improved treatment outcomes for skin rejuvenation, hair restoration, and musculoskeletal healing. Likewise, the superior platelet recovery rate ensures that clinicians can deliver the highest-quality PRP formulations with minimal loss, maximising the therapeutic benefits.
Setting the Gold Standard in PRP Technology
With this latest recognition, T-Lab™ continues to set the gold standard in PRP technology, giving medical professionals confidence in their ability to offer the most potent PRP treatments. This achievement reflects years of dedicated research and innovation in blood-derived regenerative therapies.
As the demand for high-quality PRP treatments grows, T-Lab™’s industry-leading system is poised to remain the top choice for clinics worldwide, offering unparalleled efficiency, effectiveness, and patient results.
For health professionals looking to elevate their PRP offerings, T-Lab™ represents the pinnacle of technology and clinical efficacy.
For more details on the study presented at IMCAS World Congress 2025, visit: IMCAS 2025 Session.
